中华泌尿外科杂志
中華泌尿外科雜誌
중화비뇨외과잡지
CHINESE JOURNAL OF UROLOGY
2015年
5期
337-341
,共5页
王一%刘晓强%郭战军%梁博%李常颖%吴长利%刘雨%孙光
王一%劉曉彊%郭戰軍%樑博%李常穎%吳長利%劉雨%孫光
왕일%류효강%곽전군%량박%리상영%오장리%류우%손광
锌指结构转录因子%E钙黏蛋白%膀胱癌%免疫组织化学
鋅指結構轉錄因子%E鈣黏蛋白%膀胱癌%免疫組織化學
자지결구전록인자%E개점단백%방광암%면역조직화학
Zinc finger E-box binding homeobox 1%E-cadherin%Bladder cancer%Immunohistochemistry
目的 探讨锌指结构转录因子1(zinc finger E-box binding homeobox 1,ZEB1)和E钙黏蛋白在膀胱尿路上皮癌组织和正常膀胱黏膜组织中的表达情况、相关性及其与临床病理特征的关系.方法 收集2008年3月至2011年3月86例膀胱尿路上皮癌患者的手术标本.男51例,女35例.年龄36 ~72岁,平均(64.1±10.2)岁.其中>65岁40例,≤65岁46例.均经病理检查证实为膀胱尿路上皮癌,病理分级:G128例,G2~G358例.TNM分期:Ta~T1期34例,T2~T4期52例.肿瘤单发49例,多发37例.初发55例,复发31例.16例正常膀胱黏膜组织取自BPH患者开放手术标本.年龄51 ~75岁,平均(58.6±18.4)岁.采用免疫组化染色方法分别检测ZEB1和E钙黏蛋白在膀胱癌组织及正常膀胱黏膜组织中的表达情况,分析两者在膀胱癌组织中表达的相关性,以及两者表达情况与患者临床病理特征的关系.结果 ZEB1在膀胱癌组织和正常膀胱黏膜组织中表达的阳性率分别为39.5%(34/86)和0(0/16);在高分级(G2 ~ G3)和低分级(G1)膀胱癌组织中表达的阳性率分别为48.3%(28/58)和21.4%(6/28);在T2~T4期和Ta~T1期膀胱癌组织中表达的阳性率分别为51.9% (27/52)和20.6%(7/34),差异均有统计学意义(P<0.05).E钙黏蛋白在膀胱癌组织和正常膀胱黏膜组织中表达的异常率分别为61.6% (53/86)和81.2%(13/16),差异有统计学意义(P<0.01);在高分级(G2 ~ G3)和低分级(G1)膀胱癌组织中表达的异常率分别为53.4%(31/58)和78.6%(22/28);在T2~ T4期和Ta~T1期膀胱癌组织中表达的异常率分别为51.9%(27/52)和76.5%(26/34),差异均有统计学意义(P<0.05).在膀胱癌组织中,ZEB1的阳性表达与E钙黏蛋白的异常表达间呈负相关(r =0.247,P<0.05).结论 ZEB1和E钙黏蛋白在膀胱癌组织中的表达具有负相关性,且两者的表达与膀胱癌的分期、分级密切相关.
目的 探討鋅指結構轉錄因子1(zinc finger E-box binding homeobox 1,ZEB1)和E鈣黏蛋白在膀胱尿路上皮癌組織和正常膀胱黏膜組織中的錶達情況、相關性及其與臨床病理特徵的關繫.方法 收集2008年3月至2011年3月86例膀胱尿路上皮癌患者的手術標本.男51例,女35例.年齡36 ~72歲,平均(64.1±10.2)歲.其中>65歲40例,≤65歲46例.均經病理檢查證實為膀胱尿路上皮癌,病理分級:G128例,G2~G358例.TNM分期:Ta~T1期34例,T2~T4期52例.腫瘤單髮49例,多髮37例.初髮55例,複髮31例.16例正常膀胱黏膜組織取自BPH患者開放手術標本.年齡51 ~75歲,平均(58.6±18.4)歲.採用免疫組化染色方法分彆檢測ZEB1和E鈣黏蛋白在膀胱癌組織及正常膀胱黏膜組織中的錶達情況,分析兩者在膀胱癌組織中錶達的相關性,以及兩者錶達情況與患者臨床病理特徵的關繫.結果 ZEB1在膀胱癌組織和正常膀胱黏膜組織中錶達的暘性率分彆為39.5%(34/86)和0(0/16);在高分級(G2 ~ G3)和低分級(G1)膀胱癌組織中錶達的暘性率分彆為48.3%(28/58)和21.4%(6/28);在T2~T4期和Ta~T1期膀胱癌組織中錶達的暘性率分彆為51.9% (27/52)和20.6%(7/34),差異均有統計學意義(P<0.05).E鈣黏蛋白在膀胱癌組織和正常膀胱黏膜組織中錶達的異常率分彆為61.6% (53/86)和81.2%(13/16),差異有統計學意義(P<0.01);在高分級(G2 ~ G3)和低分級(G1)膀胱癌組織中錶達的異常率分彆為53.4%(31/58)和78.6%(22/28);在T2~ T4期和Ta~T1期膀胱癌組織中錶達的異常率分彆為51.9%(27/52)和76.5%(26/34),差異均有統計學意義(P<0.05).在膀胱癌組織中,ZEB1的暘性錶達與E鈣黏蛋白的異常錶達間呈負相關(r =0.247,P<0.05).結論 ZEB1和E鈣黏蛋白在膀胱癌組織中的錶達具有負相關性,且兩者的錶達與膀胱癌的分期、分級密切相關.
목적 탐토자지결구전록인자1(zinc finger E-box binding homeobox 1,ZEB1)화E개점단백재방광뇨로상피암조직화정상방광점막조직중적표체정황、상관성급기여림상병리특정적관계.방법 수집2008년3월지2011년3월86례방광뇨로상피암환자적수술표본.남51례,녀35례.년령36 ~72세,평균(64.1±10.2)세.기중>65세40례,≤65세46례.균경병리검사증실위방광뇨로상피암,병리분급:G128례,G2~G358례.TNM분기:Ta~T1기34례,T2~T4기52례.종류단발49례,다발37례.초발55례,복발31례.16례정상방광점막조직취자BPH환자개방수술표본.년령51 ~75세,평균(58.6±18.4)세.채용면역조화염색방법분별검측ZEB1화E개점단백재방광암조직급정상방광점막조직중적표체정황,분석량자재방광암조직중표체적상관성,이급량자표체정황여환자림상병리특정적관계.결과 ZEB1재방광암조직화정상방광점막조직중표체적양성솔분별위39.5%(34/86)화0(0/16);재고분급(G2 ~ G3)화저분급(G1)방광암조직중표체적양성솔분별위48.3%(28/58)화21.4%(6/28);재T2~T4기화Ta~T1기방광암조직중표체적양성솔분별위51.9% (27/52)화20.6%(7/34),차이균유통계학의의(P<0.05).E개점단백재방광암조직화정상방광점막조직중표체적이상솔분별위61.6% (53/86)화81.2%(13/16),차이유통계학의의(P<0.01);재고분급(G2 ~ G3)화저분급(G1)방광암조직중표체적이상솔분별위53.4%(31/58)화78.6%(22/28);재T2~ T4기화Ta~T1기방광암조직중표체적이상솔분별위51.9%(27/52)화76.5%(26/34),차이균유통계학의의(P<0.05).재방광암조직중,ZEB1적양성표체여E개점단백적이상표체간정부상관(r =0.247,P<0.05).결론 ZEB1화E개점단백재방광암조직중적표체구유부상관성,차량자적표체여방광암적분기、분급밀절상관.
Objective To explore the expression,correlation and clinic-pathological characters of zinc finger E-box binding homeobox 1 (ZEB1) and E-cadherin in normal bladder tissues and bladder urothelial carcinoma(BUC).Methods Immunohistochemical staining was performed on paraffin embedded sections to detect the expression of ZEB1 and E-cadherin in 86 cases of BUC,diagnosed by pathology,between March 2008 and March 2011.Among them,51 cases were male and 35 cases were female.The mean age was (64.1 ± 10.2)years,range 36 to 72 years.40 cases were older than 65 years old,and 46 cases were less than 65 years old.The pathological classification included G1 in 28 cases,G2-G3 in 58 cases.The TNM classification showed that Ta-T1 stage in 34 cases,T2-T4 in 52 cases.Single lesion was found in 49 cases and multi lesion was found in 37 cases.55 cases were primary lesion;the other 31 cases were diagnosed as tumor recurrence.Normal bladder mucosa was obtained from 16 patients with BPH.Their age ranged from 51 to 75 years old,mean (58.6 ± 18.4) years old.Similar immunohistochemical staining about ZEB1 and E-cadherin was performed.The expression of ZEB1 and E-cadherin in different tissue and its relationship with the clinic pathological were further analyzed.Results The positive rate of ZEB1 in bladder cancer group (39.5%,34/86) was significantly higher than that in normal bladder mucosa group (0,0/16) (P < 0.01).The positive rate of ZEB1 in high grade bladder cancer (G2-G3) was 48.3% (28/58),which was significant higher than that in low grade bladder cancer (G1) (21.4%,6/28) (P <0.05);The positive rate of ZEB1 in muscle-invasive bladder cancer (T2-T4) was 51.9% (27/52),which was significant higher than that in non-muscle-invasive cancer (Ta-T1) (20.6%,7/34) (P < 0.01).The abnormal rate of E-cadherin expression in bladder cancer (61.6%,53/86) was significantly lower than that in normal bladder mueosa (81.2%,13/16) (P < 0.01).The abnormal expression rate of E-cadherin in high grade bladder cancer (G2-G3) (53.4%,31/58) was significantly lower than that in low grade bladder cancer (G1) (78.6%,22/28)(P < 0.05);The abnormal rate of E-cadherin expression in invasive bladder cancer (T2-T,4) was 51.9% (27/52),which was lower than that in non-muscle invasive (Ta-T1) cancer (76.5%,26/34) (P < 0.05).In bladder cancer,there was a negative correlation between the abnormal expression of E-cadherin and positive expression of ZEB1 (r =0.247,P < 0.05).Conclusion The expressions of ZEB1 and E-cadherin in bladder cancer were negatively correlated,which had high correlated with tumor grade and stage.